Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11524980 Synthesis of echinocandin antifungal agent

Patent 11524980 was granted and assigned to Cidara Therapeutics on December, 2022 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

Cidara Therapeutics

Current Assignee

Cidara Therapeutics

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

11524980

Date of Patent

December 13, 2022

Patent Application Number

17252579

Date Filed

June 14, 2019

Patent Citations

‌

US Patent 10702573 Dosing regimens for echinocandin class compounds

‌

US Patent 10016479 Dosing regimens for echinocandin class compounds

‌

US Patent 10369188 Methods for preventing and treating pneumocystis infections

‌

US Patent 10780144 Methods for preventing and treating pneumocystis infections

Patent Citations Received

‌

US Patent 11654196 Dosing regimens for echinocandin class compounds

Patent Primary Examiner

‌

Sergio Coffa

The present invention relates to echinocandin cyclopeptides and to methods for preparing echinocandin cyclopeptides.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11524980 Synthesis of echinocandin antifungal agent

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API